SRAD vs GENI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
SRAD
GENI
Investment Advisor Scores
GENI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SRAD | GENI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.8471 | 51.8135 | SRAD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 24.1% | 62.3% | GENI |
| Earnings Growth | -61.6% | 0.0% | GENI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.8/100 | 61.3/100 | GENI |
| Profit Margin | 1.5% | -18.9% | SRAD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | GENI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SRAD
NeutralMixed signals - no dominant trend phase, RSI 55
GENI
NeutralMixed signals - no dominant trend phase, RSI 52
Fundamentals Snapshot
| Metric | SRAD | GENI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 32.8 | 6.0 |
| Trailing P/E | 194.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.6% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 0.07 | -0.61 |
| Dividend Yield | — | — |